Table 2 Patient characteristics
Intervention group | Control group | |
|---|---|---|
(total n = 1154) | (total n = 1457) | |
Age (y): Median (min, max) | 72 (18,100) | 72 (18,102) |
Male: n (%) | 534 (46) | 688 (47) |
Length of stay (days): Median (min, max) | 4 (0,79) | 5 (0,133) |
VTE risk factors: n (%) | ||
Congestive heart failure | 140 (12) | 166 (11) |
Acute respiratory disease | 181 (16) | 133 (9) |
Acute ischemic stroke | 68 (6) | 92 (6) |
Cancer | 93 (8) | 172 (12) |
Sepsis | 145 (13) | 111 (8) |
Acute neurological disease | 24 (2) | 13 (1) |
Inflammatory bowel disease | 23 (2) | 25 (2) |
Prior VTE | 26 (2) | 22 (2) |
Immobility | 637 (55) | 806 (55) |
Bleeding risk factors: n (%) | ||
Acute bleeding | 64 (6) | 134 (9) |
At risk for bleeding | 116 (10) | 90 (6) |
Recent bleeding | 22 (2) | 5 (0) |
Coagulopathy | 93 (8) | 185 (13) |
Thrombocytopenia | 36 (3) | 50 (3) |
VTE risk profile: n (%) | ||
At risk for VTE without risk of bleeding | 436 (38) | 465 (32) |
At risk for VTE with risk of bleeding | 132 (11) | 167 (11) |
Not at risk for VTE | 586 (51) | 825 (57) |